Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23020162

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2012 Nov 8
First author
Verma S

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2013 Jun 20;368(25):2442
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    N Engl J Med. 2012 Nov 8;367(19):1847-8. doi: 10.1056/NEJMe1211736.
    note
    Source null
    related pmid
    23134386
    relationship
    Comment in

Authors and identifiers

  1. name
    Verma S
    type
    Author
  2. name
    Miles D
    type
    Author
  3. name
    Gianni L
    type
    Author
  4. name
    Krop IE
    type
    Author
  5. name
    Welslau M
    type
    Author
  6. name
    Baselga J
    type
    Author
  7. name
    Pegram M
    type
    Author
  8. name
    Oh DY
    type
    Author
  9. name
    Diéras V
    type
    Author
  10. name
    Guardino E
    type
    Author
  11. name
    Fang L
    type
    Author
  12. name
    Lu MW
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Verma S
    type
    Author
  2. name
    Miles D
    type
    Author
  3. name
    Gianni L
    type
    Author
  4. name
    Krop IE
    type
    Author
  5. name
    Welslau M
    type
    Author
  6. name
    Baselga J
    type
    Author
  7. name
    Pegram M
    type
    Author
  8. name
    Oh DY
    type
    Author
  9. name
    Diéras V
    type
    Author
  10. name
    Guardino E
    type
    Author
  11. name
    Fang L
    type
    Author
  12. name
    Lu MW
    type
    Author
bibliography ids
  1. nci-bib-a2421ad9c042a7cf3fbdfe9f
book metadata
content sha256
6ac63cccc9a1c1c05f221ee883a78836291577705d415d76ec08eac863d6f0fb
document type
citation
dois
  1. 10.1056/NEJMoa1209124
electronic publication date
display
2012 Oct 1
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:23020162
immutable id
pubmed:23020162@6ac63cccc9a1c1c05f221ee883a78836291577705d415d76ec08eac863d6f0fb
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1783-91
volume
367
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2013 Jun 20;368(25):2442
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    N Engl J Med. 2012 Nov 8;367(19):1847-8. doi: 10.1056/NEJMe1211736.
    note
    Source null
    related pmid
    23134386
    relationship
    Comment in
outcomes validated
false
pmid
23020162
provenance
batch id
1e3045de9f47a5ccd566
provider
NCBI PubMed ESummary
record sha256
43439eba29b09dfb01edf88293dead3f33e9843c0bd4d8d073a6ea085249a2c0
response sha256
0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
retrieved at
2026-09-09T23:46:50.128287+00:00
publication date
display
2012 Nov 8
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23020162/
title
Trastuzumab emtansine for HER2-positive advanced breast cancer.

Preserved source evidence · Not medical advice